Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Waters

Showing results (81-90 of 157) with videos related to

Pageof 16
Sort By:
Journal of the American Heart Association|April 26, 2019
Atorvastatin Has a Dose-Dependent Beneficial Effect on Kidney Function and Associated Cardiovascular Outcomes: Post Hoc Analysis of 6 Double-Blind Randomized Controlled TrialsLiffert Vogt, Sripal Bangalore, Rana Fayyad, et al.
The American Journal of Cardiology|May 6, 2014
Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trialsSripal Bangalore, Rana Fayyad, G Kees Hovingh, et al.
The American Journal of Cardiology|January 13, 2004
Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?David D Waters, John R Guyton, David M Herrington, et al.
Journal of Clinical Lipidology|January 10, 2018
Visit-to-visit variability of lipid measurements as predictors of cardiovascular eventsDavid D Waters, Sripal Bangalore, Rana Fayyad, et al.
Circulation|January 14, 2004
Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infectionPriscilla Y Hsue, Kamini Giri, Sara Erickson, et al.
Atherosclerosis|March 13, 2002
The effects of hydroxy-methyl-glutaryl co-enzyme A reductase inhibitors on platelet thrombus formationPaul D Thompson, Niall M Moyna, C Michael White, et al.
The American Journal of Cardiology|March 27, 2014
Effect of change in body weight on incident diabetes mellitus in patients with stable coronary artery disease treated with atorvastatin (from the treating to new targets study)Kwok-Leung Ong, David D Waters, Michael Messig, et al.
Atherosclerosis|February 22, 2005
Hormone therapy and antioxidant vitamins do not improve endothelial vasodilator function in postmenopausal women with established coronary artery disease: a substudy of the Women's Angiographic Vitamin and Estrogen (WAVE) trialMark Kelemen, Dhananjay Vaidya, David D Waters, et al.
The American Journal of Cardiology|February 1, 2015
Impact of female sex on lipid lowering, clinical outcomes, and adverse effects in atorvastatin trialsPriscilla Y Hsue, Vera A Bittner, John Betteridge, et al.
The American Journal of Cardiology|March 14, 2007
Cardiac arrest in patients who smoke crack cocainePriscilla Y Hsue, David McManus, Van Selby, et al.
Pageof 16

Showing results (81-90 of 157) with videos related to

Sort By:
Pageof 16
Journal of the American Heart Association|April 26, 2019
Atorvastatin Has a Dose-Dependent Beneficial Effect on Kidney Function and Associated Cardiovascular Outcomes: Post Hoc Analysis of 6 Double-Blind Randomized Controlled TrialsLiffert Vogt, Sripal Bangalore, Rana Fayyad, et al.
The American Journal of Cardiology|May 6, 2014
Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trialsSripal Bangalore, Rana Fayyad, G Kees Hovingh, et al.
The American Journal of Cardiology|January 13, 2004
Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?David D Waters, John R Guyton, David M Herrington, et al.
Journal of Clinical Lipidology|January 10, 2018
Visit-to-visit variability of lipid measurements as predictors of cardiovascular eventsDavid D Waters, Sripal Bangalore, Rana Fayyad, et al.
Circulation|January 14, 2004
Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infectionPriscilla Y Hsue, Kamini Giri, Sara Erickson, et al.
Atherosclerosis|March 13, 2002
The effects of hydroxy-methyl-glutaryl co-enzyme A reductase inhibitors on platelet thrombus formationPaul D Thompson, Niall M Moyna, C Michael White, et al.
The American Journal of Cardiology|March 27, 2014
Effect of change in body weight on incident diabetes mellitus in patients with stable coronary artery disease treated with atorvastatin (from the treating to new targets study)Kwok-Leung Ong, David D Waters, Michael Messig, et al.
Atherosclerosis|February 22, 2005
Hormone therapy and antioxidant vitamins do not improve endothelial vasodilator function in postmenopausal women with established coronary artery disease: a substudy of the Women's Angiographic Vitamin and Estrogen (WAVE) trialMark Kelemen, Dhananjay Vaidya, David D Waters, et al.
The American Journal of Cardiology|February 1, 2015
Impact of female sex on lipid lowering, clinical outcomes, and adverse effects in atorvastatin trialsPriscilla Y Hsue, Vera A Bittner, John Betteridge, et al.
The American Journal of Cardiology|March 14, 2007
Cardiac arrest in patients who smoke crack cocainePriscilla Y Hsue, David McManus, Van Selby, et al.
Pageof 16